SAUNDRA BRENNAN: Open Payments
NPI 1154427037 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,766 in 104 payments from 16 companies in 2025. Trend: 2023 $1,106 · 2024 $1,294 · 2025 $1,766
Food & beverage: $1,595Education: $171
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 21 | $285 |
| Janssen Biotech, Inc. | 10 | $259 |
| LEO Pharma Inc. | 11 | $169 |
| Galderma Laboratories, L.P. | 11 | $160 |
| MAYNE PHARMA COMMERCIAL LLC | 16 | $156 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $153 |
| ABBVIE INC. | 7 | $143 |
| GENZYME CORPORATION | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
Products named: TALTZ, TREMFYA, NEMLUVIO, DUPIXENT, ADBRY, SKYRIZI, ILUMYA, COSENTYX.
Industry payments across NE — which companies pay providers there.
